SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-17-024001
Filing Date
2017-04-18
Accepted
2017-04-18 12:16:11
Documents
7
Period of Report
2017-06-15
Effectiveness Date
2017-04-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A a17-7502_3def14a.htm DEF 14A 352804
3 GRAPHIC j1775024_aa001.jpg GRAPHIC 6315
4 GRAPHIC g75023dai001.gif GRAPHIC 5320
5 GRAPHIC g75023dai002.gif GRAPHIC 2733
6 GRAPHIC g75023dai003.gif GRAPHIC 2403
7 GRAPHIC g75023dai004.gif GRAPHIC 4097
8 GRAPHIC g75023bii001.gif GRAPHIC 2224
  Complete submission text file 0001104659-17-024001.txt   386554
Mailing Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110
Business Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110 6177728515
TEKLA LIFE SCIENCES INVESTORS (Filer) CIK: 0000884121 (see all company filings)

IRS No.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 811-06565 | Film No.: 17766434